% | $
Quotes you view appear here for quick access.

Arena Pharmaceuticals, Inc. Message Board

  • skunk.syrup skunk.syrup Oct 13, 2013 11:38 PM Flag

    Longs have one serious MD on their side: Dr. Vig.

    You better hope he's perfect because you position depends entirely on him being right.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • If anyone has any doubts about who has the best drug and who has the best physicians behind it let me remind you.

      These are the physicians that presented last week at The 2013 Cardio Metabolic Health Congress. Who would you listen to? Nothing against the University of Alabama Birmingham.

      VVUS Presentation One Distinguished Faculty

      W. Timothy Garvey, MD
      Butterworth Professor and Chair
      Department of Nutrition Science
      University of Alabama at Birmingham
      GRECC Investigator & Staff Physician
      Birmingham VA Medical Center
      Director, UAB Diabetes Research Center
      Birmingham, AL

      EISAI (ARNA) Presentation Four Distinguished Faulty

      Louis Aronne, MD
      Director, Comprehensive Weight Control Program
      New York-Presbyterian Hospital
      Clinical Professor of Medicine
      Weill-Cornell Medical College

      Harold Bays, MD
      Medical Director/President
      Louisville Metabolic and Atherosclerosis
      Research Center, Inc

      Lee M. Kaplan, MD, PhD
      Associate Professor of Medicine
      Harvard Medical School
      Director, Obesity, Metabolism & Nutrition Institute
      Massachusetts General Hospital

      Steven Smith, MD
      Scientific Director
      Translational Research Institute
      Sanford Burnham Medical Research Institute

    • Go back to bed. Van misses you.

    • One Doctor???!!! How about a slew of the TOP Scientists and Doctors in the world who Nominated Belviq for the US Galien Prix awards for 2013. I am sure you heard that there was 17 drugs nominated by the top scientists in the world and Belviq is one of those 17 drugs. The winner will be announced in a week's time on October 22, 2013 in NYC. You better pray that Belviq is not the 2013 Galien Prix Winner.

    • I will trust him far more than you. Market manipulation vs. medical results....eventually the medical results for weight loss will take control of the stock price. He knows and see's the value directly from patient results, and the scope of the obesity market potential. The drug is safe, it works, and patients are responding in amazing ways beyond the weight loss....sleep patterns, bad habits, other med reductions. He is experiencing patient results beyond those outlined in the medical trials. Longs have one serious drug on their side, he is just one of the medically qualified pied pipers stepping up to the plate.

      Sentiment: Buy

    • I would not have chosen the word serious. Enthusiastic , yes.

1.47-0.01(-0.68%)Feb 11 4:00 PMEST